Synaffix licenses CliCr chemistry from Cristal Therapeutics
Truly emboldened by the signed license agreement with Synaffix as it underscores the potential of our unique CliCr® technology!
This represents an important milestone in the execution of our strategy to commercialize CliCr® in different fields of diagnostic and therapeutic bioconjugates. Please contact us in case of any interest!
